Jawdrop Fireside: Unleashing the Power of Clinical Trials

 

Admission fee:FREE

 

Date
October 31, 2023

Time
16:00-20:00

Location
Molecular Sciences Research Hub (MSRH)
Imperial College London
82 Wood Lane
London W12 0BZ

Map

 

Description

Jawdrop Fireside: Life Sciences follows this February’s successful inaugural Jawdrop Summit: Life Sciences in White City Innovation District (WCID).

WCID is fast emerging as a global economic hotspot in science, technology, engineering, mathematics, medicine and business (STEMMB).

Within this thriving deep-tech innovation ecosystem, there has been an incredible growth of Life Science businesses. A key factor for this attraction has been proximity to Imperial College London and Imperial Healthcare Trust, through which Life Science businesses can access Hammersmith Hospital, the North West London Clinical Trials Alliance and Paddington Life Sciences.

Jawdrop Fireside Life Sciences brings together industry leaders, NHS representatives, and academic experts to explore how the use of clinical trials can drive innovation and improve patient outcomes. In an increasingly competitive global environment, the number of industry clinical trials initiated in the UK per year fell by 41% between 2017 and 2021. This challenge is clearly recognised by Government, regulatory and professional bodies; the panel will debate the Government’s proposals on clinical trials, the importance of fostering collaboration between industry, the NHS, and academia as well as the ethical and regulatory considerations.

KEYNOTES:

Opening: Dan Mahony, UK Government Life Sciences Investment Envoy

Closing: Dr Suki Balendra, Imperial College Healthcare NHS Trust, Director of Strategic Partnerships at Paddington Life Sciences & Life sciences Lead for the NIHR CRN North West London

PANEL – more speakers to be confirmed

  • Prof. Graham Cooke, Imperial College London, Vice Dean (Research) for the Faculty of Medicine (Chair)
  • Rob Hastings, Medical Affairs Director – Novartis UK
  • Angela McFarlane, Vice President, Strategic Planning, Northern Europe, IQVIA
  • Nahuel Villegas, CSO – Vivan Therapeutics

 

sign up
imperial_logo
upstream_logo
hf_logo